Market cap
₹235 Cr
Revenue (TTM)
₹191 Cr
P/E Ratio
44.7
P/B Ratio
2.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
7.7 %
-
ROCE
12 %
-
Industry P/E
33.3
-
EV/EBITDA
13.7
-
Debt to Equity
0.7
-
Book Value
₹80.8
-
EPS
₹5.4
-
Face value
10
-
Shares outstanding
9,973,683
10 Years Aggregate
CFO
₹93.51 Cr
EBITDA
₹118.39 Cr
Net Profit
₹40.54 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Everest Organics
| -49.8 | 15.6 | -16.9 | -36.5 | 29.6 | -3.4 | 13.6 |
|
BSE Healthcare
| 16.8 | 1.6 | -0.1 | 12.6 | 22.3 | 15.0 | 12.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Everest Organics
| 68.0 | 136.2 | 2.7 | -50.5 | -12.6 | 68.5 | 64.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Everest Organics
|
254.0 | 234.9 | 190.8 | 5.3 | 6.9 | 7.1 | 44.7 | 2.9 |
| 6,391.5 | 15,851.5 | 2,432.1 | 169.6 | 8.7 | 20.8 | 93.5 | 17.5 | |
| 2,353.1 | 17,954.0 | 2,287.3 | 678.1 | 31.4 | 19.7 | 27 | 4.9 | |
| 2,271.7 | 13,909.6 | 1,559.1 | 206.6 | 18.4 | 28.5 | 67.2 | 17.3 | |
| 1,183.0 | 16,335.1 | 3,329.6 | 720.8 | 26.3 | 18.9 | 23.1 | 3.9 | |
| 3,831.3 | 17,370.4 | 2,569.8 | 735.2 | 34.4 | 19.2 | 23.6 | 3.9 | |
| 5,999.0 | 9,722.1 | 1,490.5 | 379.9 | 31.8 | 60.2 | 25.6 | 14.8 | |
| 3,403.0 | 7,791.8 | 1,821.5 | 364.5 | 26.0 | 46.3 | 21.4 | 8.3 | |
| 926.1 | 18,203.8 | 1,682.5 | 273.5 | 21.0 | 11.1 | 61.2 | 6.8 | |
| 1,034.0 | 9,579.8 | 5,213.3 | 636.0 | 14.2 | 17.7 | 15.5 | 2.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Everest Organics
Everest Organics Limited manufactures and sells active pharmaceutical ingredients and intermediaries. The company also manufactures bulk drugs. It exports bulk drugs, intermediates, drug formulations, biologicals, Ayush and herbal, and surgical... products to the United States, Western Europe, Eastern Europe, South America, Egypt, Australia, Germany, Saudi Arabia, Dubai, China, Vietnam, Iran, Singapore, Indonesia, Bangladesh, Pakistan, Sri Lanka, and other Middle East countries. Everest Organics Limited was incorporated in 1993 and is based in Hyderabad, India. Read more
-
Incorporated
1993
-
Chairman
Venkata Ramana Narra
-
Managing Director
Srikakarlapudi Sirisha
-
Headquarters
Sangareddy, Telangana
-
Website
Looking for more details about Everest Organics Ltd.’s IPO? Explore our IPO Details page.
FAQs for Everest Organics
What is the current share price of Everest Organics Ltd Today?
The share price of Everest Organics Ltd is ₹254.00 (BSE) as of 04-Nov-2026 09:18 IST. Everest Organics Ltd has given a return of 29.58% in the last 3 years.
What is the current PB & PE ratio of Everest Organics Ltd?
The P/E ratio of Everest Organics Ltd is 44.70 times as on 03-Nov-2026, a 34 premium to its peers’ median range of 33.30 times.
The P/B ratio of Everest Organics Ltd is 2.91 times as on 03-Nov-2026, a 36 discount to its peers’ median range of 4.58 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
35.62 |
2.62 |
2025 |
0.00 |
3.55 |
2024 |
659.77 |
2.00 |
2023 |
0.00 |
1.65 |
2022 |
121.57 |
2.97 |
What is the 52 Week High and Low of Everest Organics Ltd?
The 52-week high and low of Everest Organics Ltd are Rs 536.40 and Rs 197.00 as of 04-Nov-2026.
What is the market cap of Everest Organics Ltd?
Everest Organics Ltd has a market capitalisation of ₹ 235 Cr as on 03-Nov-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Everest Organics Ltd?
Before investing in Everest Organics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.